Cargando…

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective

INTRODUCTION: The COVID-19 pandemic is now affecting all people around the world and getting worse. New antiviral medications are desperately needed other than the few approved medications that have shown no promising efficacy so far. METHODS: Here we report three blocking binders for targeting SARS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Etemadi, Ali, Moradi, Hamid Reza, Mohammadian, Farideh, Karimi-Jafari, Mohammad Hossein, Negahdari, Babak, Asgari, Yazdan, Mazloomi, Mohammadali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616691/ https://www.ncbi.nlm.nih.gov/pubmed/34849425 http://dx.doi.org/10.1016/j.genrep.2021.101452

Ejemplares similares

An Anti-TAZ Monoclonal Antibody Recognizing Cell Surface Expressed TAZ Protein in Human Tumor Cells
por: Haji Ghaffari, Mozhan, et al.
Publicado: (2023)

iMM1865: A New Reconstruction of Mouse Genome-Scale Metabolic Model
por: Khodaee, Saeideh, et al.
Publicado: (2020)

In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2
por: Jafary, Farzaneh, et al.
Publicado: (2021)

Identification of novel bacterial DNA gyrase inhibitors: An in silico study
por: Rahimi, Hamzeh, et al.
Publicado: (2016)

In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain
por: Behloul, Nouredine, et al.
Publicado: (2021)

De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein
por: Pomplun, Sebastian, et al.
Publicado: (2020)

A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
por: Fu, Ying, et al.
Publicado: (2022)

Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study
por: Ebrahim-Saraie, Hadi Sedigh, et al.
Publicado: (2021)

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
por: Lin, Yu-Chao, et al.
Publicado: (2022)

Proportion of hematological cancer patients with SARS-CoV-2 infection during the COVID-19 pandemic: A systematic review and meta-analysis
por: Jafari, Mohammadali, et al.
Publicado: (2022)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

Rapid in silico Design of Potential Cyclic Peptide Binders Targeting Protein-Protein Interfaces
por: Santini, Brianda L., et al.
Publicado: (2020)

In silico evolution of protein binders with deep learning models for structure prediction and sequence design
por: Goudy, Odessa J, et al.
Publicado: (2023)

In Silico Drug Repurposing for SARS-CoV-2 Main Proteinase and Spike Proteins
por: Maffucci, Irene, et al.
Publicado: (2020)

In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)

In silico design of quadruplex aptamers against the spike protein of SARS-CoV-2
por: Behbahani, Mandana, et al.
Publicado: (2021)

In Silico Analysis of SARS-CoV-2 Spike Proteins of Different Field Variants
por: Haseeb, Muhammad, et al.
Publicado: (2023)

Effect of different types and levels of fat addition and pellet binders on physical pellet quality of broiler feeds
por: Mohammadi Ghasem Abadi, Mohammad Hossein, et al.
Publicado: (2019)

A lectin-coupled porous silicon-based biosensor: label-free optical detection of bacteria in a real-time mode
por: Yaghoubi, Mona, et al.
Publicado: (2020)

In Silico Evaluation of the Thr58-Associated Conserved Water with KRAS Switch-II Pocket Binders
por: Leini, Renne, et al.
Publicado: (2023)

In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2
por: Jain, Anisha S., et al.
Publicado: (2021)

In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
por: Babaeekhou, Laleh, et al.
Publicado: (2021)

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody
por: Omotuyi, Olaposi, et al.
Publicado: (2022)

Different aspects in explaining how mutations could affect the binding mechanism of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2
por: Jafary, Farzaneh, et al.
Publicado: (2023)

Production of human epidermal growth factor using adenoviral based system
por: Negahdari, Babak, et al.
Publicado: (2016)

In Silico Analysis of Inhibiting Papain-like Protease from SARS-CoV-2 by Using Plant-Derived Peptides
por: Moradi, Mohammad, et al.
Publicado: (2021)

Multiple etiologies of axonal sensory motor polyneuropathy in a renal transplant recipient: a case report
por: Etemadi, Jalal, et al.
Publicado: (2011)

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy
por: Wei, Tian-zi, et al.
Publicado: (2020)

In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021)

Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study
por: Ramírez-Salinas, Gema Lizbeth, et al.
Publicado: (2020)

Interaction of Spike protein and lipid membrane of SARS-CoV-2 with Ursodeoxycholic acid, an in-silico analysis
por: Rodal Canales, Francisco Javier, et al.
Publicado: (2021)

An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
por: Shishir, Tushar Ahmed, et al.
Publicado: (2022)

Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
por: Alavi, Mehran, et al.
Publicado: (2022)

Structural dynamics of prefusion spike protein of SARS-CoV-2 and its variants
por: Derakhshani-Molayousefi, Mortaza, et al.
Publicado: (2022)

Immunotherapy for Breast Cancer Treatment
por: Simonian, Miganoosh, et al.
Publicado: (2021)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies
por: Sethi, Aaftaab, et al.
Publicado: (2020)

Synthesis and Cytotoxic Activity of Novel Indole Derivatives and Their in silico Screening on Spike Glycoprotein of SARS-CoV-2
por: Gobinath, Perumal, et al.
Publicado: (2021)

In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein
por: Kathwate, Gunderao H.
Publicado: (2022)

In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins
por: Math, Renukaradhya K, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hdoiq0okktdu2ndl4uqvutp2br